Shionogi Pharma Co., Ltd.

Form 483 issued March 15, 2019 · Kanegasaki, Japan

Inspection
Mar 4 – Mar 15, 2019
Investigator
Jiao Yang
Observations
2
Pages
2
FEI number
3002808135

In short: On March 15, 2019, FDA issued a Form 483 with 2 observations to Shionogi Pharma Co., Ltd. in Kanegasaki, Iwate (FEI 3002808135) after an inspection that ran Mar 4 – Mar 15, 2019. The investigator was Jiao Yang. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.56 (sanitation).

At a glance

Observations span 1 system, led by facilities & equipment.

Facilities & equipment1
Other1

Most cited: 21 CFR 211.56 (1×) · 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Your facility cleaning procedures in Building} Jare deficient, in that they do not include full details…

  2. 02

    Your production batch records do not always identify all facility building location and room numbers; and/or…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Shionogi Pharma Co., Ltd.?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.56 (sanitation). The opening words of each observation are shown on this page.

Who inspected Shionogi Pharma Co., Ltd.?

Jiao Yang is named on this Form 483, for the inspection of Mar 4 – Mar 15, 2019. Each investigator has a profile showing what they cite most.

When was Shionogi Pharma Co., Ltd. inspected by FDA?

The inspection ran Mar 4 – Mar 15, 2019, and the Form 483 is dated March 15, 2019.

How do I get the full Form 483 for Shionogi Pharma Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free